Works matching IS 14642662 AND DT 2006 AND VI 7

Results: 101

Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients.

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 549, doi. 10.1111/j.1468-1293.2006.00420.x

By:

Orlando, G.;
Meraviglia, P.;
Cordier, L.;
Meroni, L.;
Landonio, S.;
Giorgi, R.;
Fasolo, M.;
Faggion, I.;
Riva, A.;
Zambelli, A.;
Beretta, R.;
Gubertini, G.;
Dedivitiis, G.;
Jacchetti, G.;
Cargnel, A.

Publication type:

Article

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 487, doi. 10.1111/j.1468-1293.2006.00424.x

By:

Gazzard, B.

Publication type:

Article

A note of thanks to referees Volume 7, 2006.

Published in:: 2006
Publication type:: Other

Contents.

Published in:: 2006
Publication type:: Table of Contents

Longitudinal assessment (1995-2003) of hospitalizations of HIV-infected patients within a geographical population in Canada.

Published in:

2006

By:

Krentz HB;
Dean S;
Gill MJ

Publication type:

Journal Article

Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection.

Published in:

2006

By:

Rouzioux C;
Grangeot-Keros L;
Rudent A;
Ngo-Giang-Huong N;
Krzysiek R;
Goujard C;
Deveau C;
Le Gall M;
Meyer L;
Emilie D;
PRIMO and ANRS Study Group

Publication type:

Journal Article

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)

Published in:

2006

By:

Gazzard B;
BHIVA Writing Committee*

Publication type:

Journal Article

CD4 count and viral load time-courses in patients treated with highly active antiretroviral therapy and association with the CDC staging system.

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 504, doi. 10.1111/j.1468-1293.2006.00405.x

By:

Collazos, J.;
Knobel, H.;
Casado, J. L.

Publication type:

Article

Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection.

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 514, doi. 10.1111/j.1468-1293.2006.00406.x

By:

Adalid-Peralta, L;
Grangeot-Keros, L;
Rudent, A;
Ngo-Giang-Huong, N;
Krzysiek, R;
Goujard, C;
Deveau, C;
Le Gall, M;
Meyer, L;
Emilie, D;
Rouzioux, C

Publication type:

Article

Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response.

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 520, doi. 10.1111/j.1468-1293.2006.00414.x

By:

Fardet, L.;
Mary-Krause, M.;
Heard, I.;
Partisani, M.;
Costagliola, D.

Publication type:

Article

Lipid abnormalities in HIV/hepatitis C virus-coinfected patients.

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 530, doi. 10.1111/j.1468-1293.2006.00416.x

By:

Bedimo, R.;
Ghurani, R.;
Nsuami, M.;
Turner, D.;
Kvanli, M.-B.;
Brown, G.;
Margolis, D.

Publication type:

Article

Evaluation of nevirapine-switch strategies for HIV treatment.

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 537, doi. 10.1111/j.1468-1293.2006.00418.x

By:

Cooper, C. L.

Publication type:

Article

Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study.

Published in:

HIV Medicine, 2006, v. 7, n. 8, p. 544, doi. 10.1111/j.1468-1293.2006.00419.x

By:

Rihs, T. A.;
Begley, K.;
Smith, D. E.;
Sarangapany, J.;
Callaghan, A.;
Kelly, M.;
Post, J. J.;
Gold, J.

Publication type:

Article

Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 421, doi. 10.1111/j.1468-1293.2006.00401.x

By:

Floris-Moore, M;
Howard, AA;
Lo, Y;
Arnsten, JH;
Santoro, N;
Schoenbaum, EE

Publication type:

Article

Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 431, doi. 10.1111/j.1468-1293.2006.00402.x

By:

Reliquet, V;
Allavena, C;
Fran^çois-Brunet, C;
Perr, P;
Bellein, V;
Garr&#x00E9, M;
May, T;
Souala, F;
Besnier, J-M;
Raffi, F

Publication type:

Article

Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 437, doi. 10.1111/j.1468-1293.2006.00403.x

By:

Sungkanuparph, S;
Groger, RK;
Overton, ET;
Fraser, VJ;
Powderly, WG

Publication type:

Article

Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 442, doi. 10.1111/j.1468-1293.2006.00404.x

By:

Margot, NA;
Lu, B;
Cheng, A;
Miller, MD

Publication type:

Article

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 451, doi. 10.1111/j.1468-1293.2006.00407.x

By:

Buchacz, K;
Brooks, JT;
Tong, T;
Moorman, AC;
Baker, RK;
Holmberg, SD;
Greenberg, A

Publication type:

Article

Longitudinal assessment (1995–2003) of hospitalizations of HIV-infected patients within a geographical population in Canada.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 457, doi. 10.1111/j.1468-1293.2006.00408.x

By:

Krentz, HB;
Dean, S;
Gill, MJ

Publication type:

Article

Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 467, doi. 10.1111/j.1468-1293.2006.00409.x

By:

Aurpibul, L;
Puthanakit, T;
Siriaksorn, S;
Sirisanthana, T;
Sirisanthana, V

Publication type:

Article

Serum prostate-specific antigen levels in older men with or at risk of HIV infection.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 471, doi. 10.1111/j.1468-1293.2006.00410.x

By:

Vianna, LE;
Lo, Y;
Klein, RS

Publication type:

Article

Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.

Published in:

2006

By:

Winston, J;
Shepp, DH

Publication type:

Letter

Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 7, p. 477, doi. 10.1111/j.1468-1293.2006.00412.x

By:

Fox, J;
Dustan, S;
McClure, M;
Weber, J;
Fidler, S

Publication type:

Article

Re-audit of patients initiating antiretroviral therapy.

Published in:

2006

By:

Curtis, H;
Johnson, MA;
Brook, G

Publication type:

Letter

CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/[mu]L.

Published in:

2006

By:

Moore DM;
Hogg RS;
Yip B;
Craib K;
Wood E;
Montaner JSG

Publication type:

Journal Article

Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 411, doi. 10.1111/j.1468-1293.2006.00389.x

By:

Ingiliz, P.;
Appenrodt, B.;
Gruenhage, F.;
Vogel, M.;
Tschampa, H.;
Tasci, S.;
Rockstroh, J. K.

Publication type:

Article

Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 347, doi. 10.1111/j.1468-1293.2006.00390.x

By:

van Leth, F.;
Hall, D. B.;
Lange, J. M. A.;
Reiss, P.

Publication type:

Article

The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 351, doi. 10.1111/j.1468-1293.2006.00391.x

By:

Olawumi, H. O.;
Olatunji, P. O.

Publication type:

Article

Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 356, doi. 10.1111/j.1468-1293.2006.00392.x

By:

Coll, B.;
Alonso-Villaverde, C.;
Parra, S.;
Rabassa, A.;
Martorell, L.;
Joven, J.;
Masana, L.

Publication type:

Article

Fulminant toxoplasmosis causing fatal pneumonitis and myocarditis.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 415, doi. 10.1111/j.1468-1293.2006.00393.x

By:

Eza, D. E.;
Lucas, S. B.

Publication type:

Article

Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 361, doi. 10.1111/j.1468-1293.2006.00394.x

By:

Skiest, D.;
Brown, K.;
Hester, J.;
Moore, T.;
Crosby, C.;
Mussa, H. R.;
Hoffman-Roberts, H.;
Cooper, T.

Publication type:

Article

The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 369, doi. 10.1111/j.1468-1293.2006.00395.x

By:

Gingues, S.;
Gill, M. J.

Publication type:

Article

Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 378, doi. 10.1111/j.1468-1293.2006.00396.x

By:

Manosuthi, W.;
Thongyen, S.;
Chumpathat, N.;
Muangchana, K.;
Sungkanuparph, S.

Publication type:

Article

CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 383, doi. 10.1111/j.1468-1293.2006.00397.x

By:

Moore, D. M.;
Hogg, R. S.;
Yip, B.;
Craib, K.;
Wood, E.;
Montaner, J. S. G.

Publication type:

Article

Abnormal glucose metabolism among older men with or at risk of HIV infection.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 389, doi. 10.1111/j.1468-1293.2006.00398.x

By:

Howard, A. A.;
Floris-Moore, M.;
Lo, Y.;
Arnsten, J. H.;
Fleischer, N.;
Klein, R. S.

Publication type:

Article

Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 291, doi. 10.1111/j.1468-1293.2006.00378.x

By:

Palmieri, C.;
Dhillon, T.;
Thirlwell, C.;
Newsom-Davis, T.;
Young, A.-M.;
Nelson, M.;
Gazzard, B. G.;
Bower, M.

Publication type:

Article

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 404, doi. 10.1111/j.1468-1293.2006.00400.x

By:

Glass, T. R.;
Ungsedhapand, C.;
Wolbers, M.;
Weber, R.;
Vernazza, P. L.;
Rickenbach, M.;
Furrer, H.;
Bernasconi, E.;
Cavassini, M.;
Hirschel, B.;
Battegay, M.;
Bucher, H. C.

Publication type:

Article

Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.

Published in:

2006

By:

Schiavini M;
Angeli E;
Mainini A;
Zerbi P;
Duca PG;
Gubertini G;
Vago L;
Fociani P;
Giorgi R;
Cargnel A

Publication type:

Journal Article

'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.

Published in:

2006

By:

Barfod TS;
Sørensen HT;
Nielsen H;
Rodkjaer L;
Obel N

Publication type:

Journal Article

Demographic predictors of a positive HIV test result among clients attending a large metropolitan voluntary counselling and testing centre in Thailand.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 281, doi. 10.1111/j.1468-1293.2006.00377.x

By:

Khongphatthanayothin, M.;
Tantipaibulvut, S.;
Nookai, S.;
Chumchee, P.;
Kaldor, J.;
Phanuphak, P.

Publication type:

Article

A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.

Published in:

HIV Medicine, 2006, v. 7, n. 6, p. 397, doi. 10.1111/j.1468-1293.2006.00399.x

By:

Bickel, M.;
Zangos, S.;
Jacobi, V.;
Lutz, T.;
Knecht, G.;
Goebel, F.;
Staszewski, S.;
Klauke, S.

Publication type:

Article

HIV-1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 294, doi. 10.1111/j.1468-1293.2006.00379.x

By:

Boucher, S.;
Recordon-Pinson, P.;
Ragnaud, J. M.;
Dupon, M.;
Fleury, H.;
Masquelier, B.

Publication type:

Article

Counteracting muscle wasting in HIV-infected individuals.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 299, doi. 10.1111/j.1468-1293.2006.00380.x

By:

Dudgeon, W. D.;
Phillips, K. D.;
Carson, J. A.;
Brewer, R. B.;
Durstine, J. L.;
Hand, G. A.

Publication type:

Article

Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 311, doi. 10.1111/j.1468-1293.2006.00381.x

By:

Moore, D. M.;
Hogg, R. S.;
Yip, B.;
Wood, E.;
Harris, M.;
Montaner, J. S. G.

Publication type:

Article

A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 317, doi. 10.1111/j.1468-1293.2006.00382.x

By:

Busti, A. J.;
Tsikouris, J. P.;
Peeters, M. J.;
Das, S. R.;
Canham, R. M.;
Abdullah, S. M.;
Margolis, D. M.

Publication type:

Article

The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 323, doi. 10.1111/j.1468-1293.2006.00383.x

By:

Paton, N. I.;
Sangeetha, S.;
Earnest, A.;
Bellamy, R.

Publication type:

Article

Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985–2002.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 331, doi. 10.1111/j.1468-1293.2006.00384.x

By:

Schiavini, M.;
Angeli, E.;
Mainini, A.;
Zerbi, P.;
Duca, P. G.;
Gubertini, G.;
Vago, L.;
Fociani, P.;
Giorgi, R.;
Cargnel, A.

Publication type:

Article

National review of maternity care for women with HIV infection.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 275, doi. 10.1111/j.1468-1293.2006.00385.x

By:

McDonald, C.;
Curtis, H.;
de Ruiter, A.;
Johnson, M. A.;
Welch, J.

Publication type:

Article

Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 338, doi. 10.1111/j.1468-1293.2006.00386.x

By:

Marazzi, M. C.;
Germano, P.;
Liotta, G.;
Guidotti, G.;
Loureiro, S.;
Gomes, A. da Cruz;
Blazquez, M. C. Valls;
Narciso, P.;
Perno, C. F.;
Mancinelli, S.;
Palombi, L.

Publication type:

Article

‘Simply forgot’ is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.

Published in:

HIV Medicine, 2006, v. 7, n. 5, p. 285, doi. 10.1111/j.1468-1293.2006.00387.x

By:

Barfod, T. S.;
Sørensen, H. T.;
Nielsen, H.;
Rodkjær, L.;
Obel, N.

Publication type:

Article